[Botulinum toxin in treatment of lower limb spasticity in patients with brain damage].
[AIM] To develop and test a method of examination of patients with lower limb spasticity, to describe lower limb spasticity patterns in patients with brain damage and to assess the efficacy of abobotu
APA
Kovalenko AP, Misikov VK (2018). [Botulinum toxin in treatment of lower limb spasticity in patients with brain damage].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 118(9), 28-34. https://doi.org/10.17116/jnevro201811809128
MLA
Kovalenko AP, et al.. "[Botulinum toxin in treatment of lower limb spasticity in patients with brain damage].." Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, vol. 118, no. 9, 2018, pp. 28-34.
PMID
30335069
Abstract
[AIM] To develop and test a method of examination of patients with lower limb spasticity, to describe lower limb spasticity patterns in patients with brain damage and to assess the efficacy of abobotulinumtoxin A (dysport) in the rehabilitation of patients with stroke.
[MATERIAL AND METHODS] Spasticity rating scales (MAS and Tardieu), the Barthel index, the Rankin scale , the Rivermead Mobility Index, the Hauser Ambulation Index, a comfortable walking test were used. Treatment satisfaction was assessed with the Visual analogue scale. Abobotulinumtoxin A (dysport) was used for treatment of lower limb spasticity.
[RESULTS AND CONCLUSION] Two most common patterns (dynamic and static) were identified in patients with post-stroke spasticity and the method of testing spasticity was developed. The prevalence of spasticity in individual muscles of the lower extremity was estimated as well. An analysis of the efficacy of dysport and a sensitive analysis of the scales used in the study were carried out.
[MATERIAL AND METHODS] Spasticity rating scales (MAS and Tardieu), the Barthel index, the Rankin scale , the Rivermead Mobility Index, the Hauser Ambulation Index, a comfortable walking test were used. Treatment satisfaction was assessed with the Visual analogue scale. Abobotulinumtoxin A (dysport) was used for treatment of lower limb spasticity.
[RESULTS AND CONCLUSION] Two most common patterns (dynamic and static) were identified in patients with post-stroke spasticity and the method of testing spasticity was developed. The prevalence of spasticity in individual muscles of the lower extremity was estimated as well. An analysis of the efficacy of dysport and a sensitive analysis of the scales used in the study were carried out.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | dysport
|
보툴리눔독소 주사 | dict | 3 | |
| 시술 | abobotulinumtoxin
|
보툴리눔독소 주사 | dict | 2 | |
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 |
MeSH Terms
Botulinum Toxins, Type A; Brain; Humans; Leg; Muscle Spasticity; Neuromuscular Agents; Stroke; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (2)
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.